https://carolinaurologicresearchcenter.com/wp-content/uploads/Radium-223-For-mCRPC.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-02-18 11:41:482016-02-18 11:41:48Radium-223 For mCRPC: The Urologist Perspective.
https://carolinaurologicresearchcenter.com/wp-content/uploads/2.12-Enzalutamide-Increases.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-02-15 08:36:462016-02-15 13:39:19Study Finds Enzalutamide Increases Progression-Free Survival vs Bicalutamide in Metastatic Prostate Cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/1.29-TreatmentWithRadium.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-01-29 16:40:112016-01-29 16:41:26When to Initiate Treatment With Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/1.25-Enzalutamide.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-01-25 10:49:412016-01-25 10:49:41Enzalutamide More Effective than Bicalutamide in mCRPC Patients
https://carolinaurologicresearchcenter.com/wp-content/uploads/1.14-Radium-223.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-01-14 11:17:312016-01-14 11:17:31Radium-223 For mCRPC: The Urologist Perspective – Presented by Neal Shore, MD.
https://carolinaurologicresearchcenter.com/wp-content/uploads/1.14-ASCO-GU-2016.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-01-14 11:14:172016-01-14 11:14:17ASCO GU 2016 – New treatment options in metastatic prostate cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/1.8-GrandStrand-1.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-01-08 15:54:592016-01-08 15:58:48Grand Strand home to internationally recognized research professionals (See page 6 & 7)
https://carolinaurologicresearchcenter.com/wp-content/uploads/12.1-PeerCME.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2016-01-04 12:36:482016-01-04 15:11:45Targeting Mechanisms of Resistance to Androgen-Receptor Signalling Agents for Castration-Resistant Prostate Cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/12.1-Prolaris.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-12-01 09:09:212016-01-04 13:23:23Dr. Shore Conducts the Poster Presentation at the SUO 2015 Conference in Washington, DC “Significant Reduction in Therapeutic Burden from Use of CCP Test in Treatment Decisions among Newly Diagnosed Prostate Cancer Patients in a Large Prospective Registry” Please join us Wednesday, 12/2 • 4:30pm
https://carolinaurologicresearchcenter.com/wp-content/uploads/11.30-GeonomicTestingNewTool.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-11-30 10:48:142015-11-30 10:48:14Genomic Testing Offering A New Tool In Prostate Cancer Treatment Decisions
